BSE Live
Sep 19, 16:01Prev. Close
53.96
Open Price
53.99
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Sep 19, 15:59Prev. Close
53.99
Open Price
54.00
Bid Price (Qty.)
54.14 (940)
Offer Price (Qty.)
0.00 (0)
Key Financial Ratios of Morepen Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
Per Share Ratios | ||||||
Basic EPS (Rs.) | 1.90 | 2.17 | 0.92 | 2.25 | 2.10 | |
Diluted EPS (Rs.) | 1.90 | 2.17 | 0.92 | 1.94 | 2.09 | |
Cash EPS (Rs.) | 2.30 | 2.60 | 1.26 | 2.56 | 2.72 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 21.56 | 17.39 | 15.26 | 12.52 | 8.92 | |
Book Value [InclRevalReserve]/Share (Rs.) | 21.56 | 17.39 | 15.26 | 12.52 | 8.92 | |
Dividend / Share(Rs.) | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue from Operations/Share (Rs.) | 28.37 | 30.08 | 26.19 | 30.33 | 24.73 | |
PBDIT/Share (Rs.) | 3.09 | 3.41 | 1.62 | 2.92 | 2.76 | |
PBIT/Share (Rs.) | 2.64 | 2.98 | 1.27 | 2.47 | 2.14 | |
PBT/Share (Rs.) | 2.51 | 2.91 | 1.23 | 2.63 | 2.10 | |
Net Profit/Share (Rs.) | 1.85 | 2.17 | 0.90 | 2.12 | 2.10 | |
Profitability Ratios | ||||||
PBDIT Margin (%) | 10.87 | 11.34 | 6.20 | 9.61 | 11.16 | |
PBIT Margin (%) | 9.30 | 9.91 | 4.85 | 8.15 | 8.63 | |
PBT Margin (%) | 8.85 | 9.68 | 4.70 | 8.66 | 8.47 | |
Net Profit Margin (%) | 6.53 | 7.21 | 3.45 | 6.97 | 8.47 | |
Return on Networth / Equity (%) | 8.59 | 12.47 | 5.92 | 16.89 | 23.49 | |
Return on Capital Employed (%) | 11.48 | 16.45 | 7.98 | 18.74 | 20.35 | |
Return on Assets (%) | 5.90 | 8.67 | 4.18 | 9.78 | 11.12 | |
Total Debt/Equity (X) | 0.07 | 0.03 | 0.03 | 0.03 | 0.04 | |
Asset Turnover Ratio (%) | 1.04 | 1.29 | 1.25 | 1.54 | 131.25 | |
Liquidity Ratios | ||||||
Current Ratio (X) | 2.40 | 2.39 | 2.51 | 1.68 | 1.31 | |
Quick Ratio (X) | 1.78 | 1.77 | 1.79 | 1.04 | 0.86 | |
Inventory Turnover Ratio (X) | 6.14 | 4.09 | 3.33 | 3.73 | 6.56 | |
Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Valuation Ratios | ||||||
Enterprise Value (Cr.) | 2,654.43 | 2,127.55 | 1,281.86 | 1,721.74 | 1,395.26 | |
EV/Net Operating Revenue (X) | 1.71 | 1.38 | 0.96 | 1.19 | 1.25 | |
EV/EBITDA (X) | 15.69 | 12.20 | 15.44 | 12.35 | 11.24 | |
MarketCap/Net Operating Revenue (X) | 1.69 | 1.40 | 0.98 | 1.21 | 1.30 | |
Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Price/BV (X) | 2.22 | 2.42 | 1.68 | 2.92 | 3.60 | |
Price/Net Operating Revenue | 1.69 | 1.40 | 0.98 | 1.21 | 1.30 | |
Earnings Yield | 0.04 | 0.05 | 0.04 | 0.06 | 0.07 |
12.08.2025
Morepen Lab Consolidated June 2025 Net Sales at Rs 425.24 crore, down 6.59% Y-o-Y
07.08.2025
Morepen Lab Standalone June 2025 Net Sales at Rs 391.28 crore, up 1.46% Y-o-Y
13.05.2025
Morepen Lab Standalone March 2025 Net Sales at Rs 381.94 crore, down 2.72% Y-o-Y
12.05.2025
Morepen Lab Consolidated March 2025 Net Sales at Rs 465.85 crore, up 10.11% Y-o-Y